As part of OncoDaily’s special virtual coverage of the 22nd International Conference of the Society for Integrative Oncology (SIO), we are pleased to feature an exclusive conversation with Dr. Eleanor Walker, an internationally recognized leader in integrative oncology, radiation oncology, and equitable cancer care.
The Society for Integrative Oncology continues to lead the global movement toward evidence-based, patient-centered cancer care that combines conventional oncology with integrative therapies. This year’s 22nd International Conference brought together experts from around the world to share innovations, research breakthroughs, and collaborative strategies shaping the future of integrative oncology. OncoDaily’s virtual coverage highlights these voices and brings them to a wider global audience.
A Leader in Integrative and Equitable Cancer Care
Dr. Eleanor Walker serves as a Radiation Oncologist and the Medical Director of Integrative Services at the Henry Ford Cancer Institute. She also leads as Division Director of Breast Services and serves as the Institutional Principal Investigator for NRG Oncology. Beyond her clinical leadership, Dr. Eleanor Walker chairs the Diversity, Equity, Inclusion, and Justice Committee, reflecting her deep commitment to equitable access and representation in cancer care. She is also the Chair of the Society for Integrative Oncology (SIO) 2026 Conference, which will be held in Detroit.
Her research portfolio is equally impactful. Dr. Eleanor Walker leads the ExCITE trial, a study exploring lifestyle interventions during and after cancer treatment, and has conducted pioneering research on acupuncture for breast cancer patients. She has co‑led initiatives to improve minority representation in clinical trials and has contributed significantly to reducing disparities in prostate cancer outcomes among Black men. Her work demonstrates how integrative oncology can bridge science, compassion, and equity to transform patient care.
Highlights from the Conversation
In this interview, Dr. Eleanor Walker reflects on what made the 22nd SIO Conference meaningful — from the global exchange of ideas to the shared commitment to advancing integrative oncology. She discusses how the conference theme of “Bridging Cultures, Embracing Innovation, and Fostering Unity” resonates deeply with her work.
Dr. Eleanor Walker shares insights from her leadership at Henry Ford, describing how integrative services have evolved within her institution and how these lessons can inform broader oncology practice. She speaks about the ExCITE trial and the growing evidence supporting lifestyle interventions as part of comprehensive cancer care.
The conversation also explores her research on acupuncture and symptom management, and how integrative therapies can be more widely adopted in mainstream oncology. Dr. Eleanor Walker emphasizes the importance of equitable access, noting both the challenges and opportunities in ensuring that integrative oncology reaches underserved communities.
As chair of the DEIJ Committee, Dr. Eleanor Walker discusses how diversity and inclusion must shape the future of integrative oncology research and practice. She highlights the need for representation, culturally informed care, and community‑centered approaches.
On a personal note, Dr. Eleanor Walker reflects on what continues to inspire her — the resilience of patients, the power of integrative approaches to improve quality of life, and the ongoing pursuit of equity in cancer care.